Free Trial

Medifast Q3 2023 Earnings Report

Medifast logo
$15.49 -0.11 (-0.69%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Medifast EPS Results

Actual EPS
$2.12
Consensus EPS
$1.02
Beat/Miss
Beat by +$1.10
One Year Ago EPS
$3.32

Medifast Revenue Results

Actual Revenue
$235.87 million
Expected Revenue
$232.10 million
Beat/Miss
Beat by +$3.77 million
YoY Revenue Growth
-39.60%

Medifast Announcement Details

Quarter
Q3 2023
Time
After Market Closes

Conference Call Resources

Medifast Earnings Headlines

Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis
Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …
3 Consumer Stocks to Drop Right Now
See More Medifast Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Medifast? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medifast and other key companies, straight to your email.

About Medifast

Medifast (NYSE:MED), through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

View Medifast Profile

More Earnings Resources from MarketBeat